Data de publicação: 07/05/2024 - 17:09
The Wolbachia Method, patented by the World Mosquito Program (WMP) and conducted in Brazil by Fiocruz, with funding from the Ministry of Health, is experiencing a moment of expansion in the country: the program in Joinville (SC), Foz do Iguaçu (PR) and Londrina (PR) enters a new phase with community engagement work, and the biofactory in Rio de Janeiro receives state-of-the-art equipment to scale up its production of Wolbito mosquitoes....
Notícias
Data de publicação: 03/05/2024 - 14:38
The president of Fiocruz, Mario Moreira, visited Spain and Portugal between April 18th and 24th, seeking to deepen institutional relations in areas considered strategic with Fiocruz's traditional partners. The visits to the two countries took place shortly after Fiocruz's mission to the United States.
Visit of the Fiocruz delegation to the Nova Medical School campus, in Lisbon (photo: publicity)
"The meetings in Spain and...
Notícias
Data de publicação: 30/04/2024 - 16:39
President of Fiocruz, Mario Moreira led a mission to the United States between April 15 and 17 seeking to strengthen collaborative ties and promote significant advances with partners in priority areas for the institution. Also taking part in the mission were the vice president of Health Production and Innovation, Marco Aurélio Krieger, the director of the Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz), Maurício Zuma...
Notícias
Data de publicação: 30/04/2024 - 10:07
A study published in the British journal The Lancet analyzes fertility rates around the world and points out that, by the year 2100, only 6 (3%) out of 204 countries will have sustainable levels of births for sustainable population replacement. The paper analyzes data from 1950 to 2021 and projects for 2050 and 2100. The research is the result of a partnership between an international study group called Global Burden of Diseases. The team...
Notícias
Data de publicação: 29/04/2024 - 12:15
Pasteur Fiocruz Center for Immunology and Immunotherapy
Address
Rua São José, S/N - Precabura, Eusébio - CE, 61773-270, Brasil
Contacts
Center's secretariat
Phone: +55 (85) 3215-6980
Email: adm.cpfii@fiocruz.br
Press (TBD)
Phone:
Email:
Páginas Institucionais para Especiais
Data de publicação: 29/04/2024 - 12:15
The Center's activities include organizing courses and other innovative bilateral and multilateral academic activities in the areas of expertise covered by the researchers involved in the cooperation.
Check back here for upcoming opportunities.
Páginas Institucionais para Especiais
Data de publicação: 29/04/2024 - 12:14
The Pasteur-Fiocruz Center for Immunology and Immunotherapy works in three priority scientific areas: cancer, infectious and neglected diseases, and autoimmune, neurodegenerative and inflammatory diseases.
Research groups and associated projects:
1) Structural computational biology (João Hermínio Martins da Silva Sena).
Associated projects:
- Development of inhibitors for the treatment of neurodegenerative diseases...
Páginas Institucionais para Especiais
Data de publicação: 29/04/2024 - 12:14
The Pasteur Fiocruz Center on Immunology and Immunotherapy brings together scientists from the Institut Pasteur and Fiocruz to develop integrative approaches to improve the treatment of infectious diseases, such as COVID-19, and non-communicable diseases, such as cancer, using immunotherapies, considered an important public health strategy.
Immunotherapy is a treatment that dynamically modulates the immune system, promoting the body's...
Páginas Institucionais para Especiais
Data de publicação: 29/04/2024 - 12:13
The Pasteur Fiocruz Center on Immunology and Immunotherapy is a collaborative project between the Institut Pasteur and Fiocruz that brings together researchers from the institutions with an integrative approach to improving the treatment of infectious and non-communicable diseases through immunotherapy.
Located at Fiocruz Ceará, in Eusébio, in the Metropolitan Region of Fortaleza, the Center has a laboratory structure and...
Páginas Institucionais para Especiais
Data de publicação: 25/04/2024 - 15:30
A study led by the Oswaldo Cruz Institute (IOC/Fiocruz) in partnership with British institutions opens the door to the development of new treatments for schistosomiasis. The disease affects 200 million people in 78 countries, including Brazil. It also belongs to the group of neglected diseases, which are associated with poverty and receive low investment in prevention, diagnosis and treatment from the pharmaceutical industry and public policies...
Notícias
Data de publicação: 22/04/2024 - 16:10
Fiocruz has taken another important step towards strengthening and implementing institutional initiatives and policies in favor of ethnic-racial and gender equity, diversity and inclusion. On Tuesday and Wednesday (April 11th and 12th, 2023), the Foundation launched the Ethnic-Racial and Gender Equity Policy and presented to the internal community the new Coordination of Equity, Diversity, Inclusion and Affirmative Policies (Cedipa), established...
Notícias
Data de publicação: 16/04/2024 - 15:33
The Laboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies of the Oswaldo Cruz Institute (IOC/Fiocruz) is part of a new cooperation network of the World Health Organization (WHO) to monitor the different types of coronavirus. Called CoViNet, the initiative is an offshoot of the network of reference laboratories set up by WHO at the start of the public health emergency caused by Sars-CoV-2. The group brings together...
Notícias
Data de publicação: 16/04/2024 - 15:12
Fiocruz hosted, from April 8th to 12th, the Fiocruz-Pasteur Network International Course on bioproduction, intellectual property and technology transfer. In the auditorium of the Rocha Lima Pavilion, on the Manguinhos Campus in Rio de Janeiro, 11 foreign students and 7 students from different units of the Foundation discussed topics such as research, development, production, quality control, clinical studies, regulatory issues and the...
Notícias
Data de publicação: 16/04/2024 - 14:30
Fiocruz Pernambuco has created a 100% national ingredient to be added to the rapid screening test for the diagnosis of visceral leishmaniasis (VL). The product can be used for both the human and canine populations, being the first with this dual efficacy. The product has already been assessed in laboratories and will soon be implemented in the field. VL is an infectious disease transmitted by the drain fly that can affect both humans and animals...
Notícias
Data de publicação: 12/04/2024 - 11:02
During dengue epidemics, the resulting deaths, with rare exceptions, are avoidable. Dengue does not kill. What kills is the lack of care and attention to the signs of worsening that can appear, especially when the fever disappears. This neglected moment leads to avoidable serious cases and deaths.
Most of the avoidable deaths from dengue are the result of several errors, three of which stand out. The first is when patients or their families...
Notícias
Data de publicação: 11/04/2024 - 11:14
A survey of indigenous Yanomami people, from the Ninam subgroup, from nine villages located in Roraima, showed that all participants were contaminated by mercury. The highest levels of exposure were detected in indigenous people living in the villages closest to the illegal gold mines. The study Impact of Mercury on Protected Areas and Forest Peoples in the Amazon: An Integrated Health-Environment Approach was conducted by the Sergio Arouca...
Notícias
Data de publicação: 11/04/2024 - 10:02
In front of representatives from 24 countries, Fiocruz opened on 4/3, and hosted until 4/5, the Second Global Workshop for countries presenting Voluntary National Reviews (VNRs), part of a series of three meetings organized by the United Nations to draw up proposals to be taken to the UN High-Level Political Forum on Sustainable Development (HLPF) in July. This is the first time the workshop has been held in Latin America, and its opening was...
Notícias
Data de publicação: 03/04/2024 - 16:03
The Institute of Technology on Immunobiologicals (Bio-Manguinhos/Fiocruz) and the pharmaceutical company Sanofi signed a Memorandum of Understanding last Wednesday (3/27) that reaffirms their mutual interest in establishing further collaborations in the field of immunization. In January this year, the institutions signed a technology transfer agreement for the domestic production of the acellular hexavalent vaccine. The immunizer offers...
Notícias
Data de publicação: 03/04/2024 - 14:29
Fiocruz, through the Institute of Drug Technology (Farmanguinhos/Fiocruz) and the René Rachou Institute (IRR/Fiocruz Minas), has signed a partnership agreement for research, development and innovation (RD&I) with the French pharmaceutical company Servier. The aim is to enable research into cancer treatments using natural samples. The event was attended by the presidents of France, Emmanuel Macron, and of Fiocruz, Mario Moreira....
Notícias
Data de publicação: 01/04/2024 - 14:36
Last week, on a trip to China, Fiocruz was able to strengthen partnerships and prospect future cooperation in health technology and innovation, especially in the areas of vaccines, biologicals and advanced therapies. The Foundation's vice president for Health Production and Innovation, Marco Krieger, and the director of the Immunobiological Technology Institute (Bio-Manguinhos), Maurício Zuma, were in the Asian country to visit health...
Notícias
Data de publicação: 27/03/2024 - 14:05
The historic Fiocruz complex in Manguinhos, in Northern Rio de Janeiro, is a candidate for World Heritage status by the United Nations Educational, Scientific and Cultural Organization (UNESCO). The institution is now part of the tentative list of sites that can become Cultural, Natural and Mixed World Heritage Sites, a primary and obligatory stage for any property to begin the process of recognition.
Inscription of the historical complex...
Notícias
Data de publicação: 27/03/2024 - 11:25
With international partners, Fiocruz has launched a research project that aims to contribute to the health of populations and ecosystems in the Amazon and East Africa in the face of climate change and environmental degradation. The aim is to establish information systems to support local communities in border areas in assessing the impacts of environmental transformations on their well-being and in developing actions to prevent, adapt to and...
Notícias
Data de publicação: 26/03/2024 - 15:34
A survey carried out by Fiocruz/Unifase's Observatory of Children's Health (Observa Infância) reveals that dengue fever has hit children up to the age of 5 hardest in 2024. The analysis shows that adolescents between the ages of 10 and 14 have the highest number of cases recorded this year, while children under the age of 5 have the highest fatality rates, followed by those between the ages of 5 and 9. Observa Infância...
Notícias
Data de publicação: 26/03/2024 - 09:20
Fiocruz, a foundation from the Brazilian government's Ministry of Health, and Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to advanced medicinal cures for all patients, everywhere, today announced a collaboration to develop local manufacturing of chimeric antigen receptor (CAR)-T cell and stem cell gene therapies for oncology, infectious, and genetic...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
